{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:23:29Z","timestamp":1787955809341,"version":"build-2784847793"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"University of Pittsburgh Brain Institute and National Institute on Aging"},{"DOI":"10.13039\/100000049","name":"NIA","doi-asserted-by":"publisher","award":["P50 AG005133"],"award-info":[{"award-number":["P50 AG005133"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Neurotoxic side effects of traditional systemic chemotherapy are abundantly described. The introduction of newly developed biologic therapeutics and cellular immune effector therapies has expanded the spectrum of neurotoxicity. Multifocal necrotizing leukoencephalopathy (MNL) is a pathologic condition of unknown etiology that has been observed in patients after prolonged critical illness. We observed a case of MNL in a patient treated with extensive multimodal therapy including chimeric antigen receptor T cells. A month before death, MRI demonstrated signs of inflammation and developing edema in brainstem structures. At autopsy the abnormal MRI regions showed a wave-like loss of microglia with hemorrhagic MNL in regions closest to the brain surface. These findings reiterate the susceptibility of white matter to antineoplastic therapy and suggest new mechanisms of neurotoxicity when traditional chemotherapy is combined with biologic or cellular effector therapy.<\/jats:p>","DOI":"10.1093\/jnen\/nlaa099","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T06:25:39Z","timestamp":1600669539000},"page":"1115-1121","source":"Crossref","is-referenced-by-count":11,"title":["Multifocal Necrotizing Leukoencephalopathy With Preferential Microglia Toxicity in a Patient Treated With Chimeric Antigen Receptor T-Cells and Review of the Literature"],"prefix":"10.1093","volume":"79","author":[{"given":"Daniel F","family":"Marker","sequence":"first","affiliation":[{"name":"Division of Neuropathology, Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia K","family":"Kofler","sequence":"additional","affiliation":[{"name":"Division of Neuropathology, Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A","family":"Mettenburg","sequence":"additional","affiliation":[{"name":"Division of Neuroradiology, Department of Radiology, University of Pittsburgh Medical Center , Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mounzer E","family":"Agha","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, Mario Lemieux Center for Blood Cancers , Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clayton A","family":"Wiley","sequence":"additional","affiliation":[{"name":"Division of Neuropathology, Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,15]]},"reference":[{"key":"2024032523352746200_nlaa099-B1","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0046-8177(93)90140-C","article-title":"Multifocal necrotizing leukoencephalopathy with pontine predilection in immunosuppressed patients: A clinicopathologic review of 16 cases","volume":"24","author":"Anders","year":"1993","journal-title":"Hum Pathol"},{"key":"2024032523352746200_nlaa099-B2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/jnen\/nlz003","article-title":"Multifocal necrotizing leukoencephalopathy: Expanding the clinicopathologic spectrum","volume":"78","author":"Premji","year":"2019","journal-title":"J Neuropathol Exp Neurol"},{"key":"2024032523352746200_nlaa099-B3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/1097-0142(197502)35:2<291::AID-CNCR2820350202>3.0.CO;2-V","article-title":"Disseminated necrotizing leukoencephalopathy: A complication of treated central nervous system leukemia and lymphoma","volume":"35","author":"Rubinstein","year":"1975","journal-title":"Cancer"},{"key":"2024032523352746200_nlaa099-B4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric antigen receptor therapy","volume":"379","author":"June","year":"2018","journal-title":"N Engl J Med"},{"key":"2024032523352746200_nlaa099-B5","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1182\/blood-2018-12-893396","article-title":"Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells","volume":"133","author":"Karschnia","year":"2019","journal-title":"Blood"},{"key":"2024032523352746200_nlaa099-B6","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N Engl J Med"},{"key":"2024032523352746200_nlaa099-B7","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N Engl J Med"},{"key":"2024032523352746200_nlaa099-B8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1158\/2159-8290.CD-NB2017-169","article-title":"JCAR015 in ALL: A Root-Cause Investigation","volume":"8","year":"2018","journal-title":"Cancer Discov"},{"key":"2024032523352746200_nlaa099-B9","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1158\/2159-8290.CD-17-0698","article-title":"Endothelial activation and blood-brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR-T cells","volume":"7","author":"Gust","year":"2017","journal-title":"Cancer Discov"},{"key":"2024032523352746200_nlaa099-B10","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/jnen\/nly064","article-title":"Neuropathology of a case with fatal car t-cell-associated cerebral edema","volume":"77","author":"Torre","year":"2018","journal-title":"J Neuropathol Exp Neurol"},{"key":"2024032523352746200_nlaa099-B11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ana.25502","article-title":"Glial injury in neurotoxicity after pediatric CD19-directed chimeric antigen receptor T cell therapy","volume":"86","author":"Gust","year":"2019","journal-title":"Ann Neurol"},{"key":"2024032523352746200_nlaa099-B12","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2567.2007.02752.x","article-title":"CD22: An inhibitory enigma","volume":"123","author":"Walker","year":"2008","journal-title":"Immunology"},{"key":"2024032523352746200_nlaa099-B13","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.2147\/DDDT.S150317","article-title":"Inotuzumab ozogamicin: A CD22 mAb-drug conjugate for adult relapsed or refractory B-cell precursor acute lymphoblastic leukemia","volume":"12","author":"Yurkiewicz","year":"2018","journal-title":"Drug Des Devel Ther"},{"key":"2024032523352746200_nlaa099-B14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"2024032523352746200_nlaa099-B15","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3340\/jkns.2011.50.4.304","article-title":"Leukoencephalopathy and disseminated necrotizing leukoencephalopathy following intrathecal methotrexate chemotherapy and radiation therapy for central nerve system lymphoma or leukemia","volume":"50","author":"Kim","year":"2011","journal-title":"J Korean Neurosurg Soc"},{"key":"2024032523352746200_nlaa099-B16","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.bbmt.2010.04.003","article-title":"Toxic leukoencephalopathy following fludarabine-associated hematopoietic cell transplantation","volume":"17","author":"Beitinjaneh","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"2024032523352746200_nlaa099-B17","first-page":"5953","article-title":"Fludarabine phosphate (NSC 312878) infusions for the treatment of acute leukemia: Phase I and neuropathological study","volume":"46","author":"Spriggs","year":"1986","journal-title":"Cancer Res"},{"key":"2024032523352746200_nlaa099-B18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41586-019-1088-4","article-title":"CD22 blockade restores homeostatic microglial phagocytosis in ageing brains","volume":"568","author":"Pluvinage","year":"2019","journal-title":"Nature"},{"key":"2024032523352746200_nlaa099-B19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/glia.20009","article-title":"Neuronal expression of CD22: Novel mechanism for inhibiting microglial proinflammatory cytokine production","volume":"46","author":"Mott","year":"2004","journal-title":"Glia"}],"container-title":["Journal of Neuropathology &amp; Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/79\/10\/1115\/33892211\/nlaa099.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/79\/10\/1115\/33892211\/nlaa099.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T23:54:05Z","timestamp":1711410845000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnen\/article\/79\/10\/1115\/5909360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,15]]},"references-count":19,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,9,15]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnen\/nlaa099","relation":{},"ISSN":["0022-3069","1554-6578"],"issn-type":[{"value":"0022-3069","type":"print"},{"value":"1554-6578","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,9,15]]}}}